Follow the Torrent Pharma share price and the full management transaction log of the company, a publicly traded company based in India. Shares trade on the IN market, under the oversight of SEBI (PIT + SAST). Market capitalisation: €1,700.1bn. The latest transaction was reported on 3 June 2026 (Acquisition). Among the most active insiders: Geena Malhotra. Every trade is free.
4
Insider Decl.
n/a
Thresholds
€21,550
4 ops.
Buy Volume
n/a
n/a
Sell Volume
13Σ signal
Buys €21,550n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 14,764 of 29,068 companies
51.6
score / 100
Value
31
Quality
73
FCF yld1.4%
Earn yld1.3%
EV/EBITDA41.6x
ROE27%
Gross mgn74%
Net mgn16%
Debt/EBITDA3.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
200 shares@ ₹4,003.0033.6% of flowEquity SharesMarket PurchaseSEBI:077a2a4bcaa82b96de02c48e1b4e921e78eb9562
Canonical exit: 30 Aug 2026 (T+90)
4 of 4 declarations
About Torrent Pharma
Torrent Pharma is an Indian pharmaceutical company specializing in the production of generic drugs and pharmaceutical products. It is listed on the Bombay Stock Exchange.